[{"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-001", "question": "A 3-week-old infant presents after an apparent life-threatening event with prolonged apnea requiring bag-mask ventilation. Polysomnography demonstrates profound hypoventilation during sleep with PaCO2 >60 mmHg. Genetic testing reveals a heterozygous non-polyalanine repeat expansion mutation in PHOX2B. Which of the following is the most appropriate next step in management?", "options": ["Initiate non-invasive ventilation with backup rate of 12 breaths/min and pressure support of 10 cm H2O", "Perform rectal suction biopsy to evaluate for Hirschsprung disease before initiating ventilation", "Initiate non-invasive ventilation with backup rate >20 breaths/min and avoid all opioid analgesics", "Prescribe supplemental oxygen at 0.5 L/min and schedule genetic counseling", "Admit for 24-hour video EEG to rule out seizure disorder"], "answer": "C", "answer_index": 2, "explanation": "Congenital central hypoventilation syndrome with non-polyalanine PHOX2B mutations requires aggressive ventilatory support with backup rates >20 breaths/min to prevent hypercapnia-induced neuronal injury. These patients have extreme sensitivity to sedatives, particularly opioids, which can precipitate fatal apnea. While Hirschsprung disease is associated with certain PHOX2B mutations, it does not precede the need for immediate ventilatory support. Standard backup rates of 12 are insufficient, and oxygen alone worsens hypoventilation.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a clear case of Congenital Central Hypoventilation Syndrome (CCHS) confirmed by a PHOX2B NPARM mutation. The clinical priority is establishing adequate ventilation. Among the choices, Option C is the unique best answer. It correctly identifies the need for a higher backup rate (>20 breaths/min) suitable for an infant (who has a higher physiologic respiratory rate than adults) and highlights the critical contraindication of opioids in CCHS patients due to respiratory depression sensitivity. Option A suggests a backup rate of 12, which is dangerously low for a 3-week-old infant who will be totally dependent on the ventilator during sleep. Option B prioritizes a biopsy over the immediate ABCs (airway/breathing). Option D (oxygen alone) is dangerous as it does not address hypoventilation and may mask hypoxemia. While current guidelines (e.g., ATS) typically recommend tracheostomy over non-invasive ventilation (NIV) for infants to ensure a secure airway, NIV is the only viable ventilation option provided in the list, and Option C describes the correct physiologic parameters and safety precautions relative to Option A. Thus, the item is logically valid and medically sound as a 'best answer' judgment.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a clear case of Congenital Central Hypoventilation Syndrome (CCHS) confirmed by a PHOX2B NPARM mutation. The clinical priority is establishing adequate ventilation. Among the choices, Option C is the unique best answer. It correctly identifies the need for a higher backup rate (>20 breaths/min) suitable for an infant (who has a higher physiologic respiratory rate than adults) and highlights the critical contraindication of opioids in CCHS patients due to respiratory depression sensitivity. Option A suggests a backup rate of 12, which is dangerously low for a 3-week-old infant who will be totally dependent on the ventilator during sleep. Option B prioritizes a biopsy over the immediate ABCs (airway/breathing). Option D (oxygen alone) is dangerous as it does not address hypoventilation and may mask hypoxemia. While current guidelines (e.g., ATS) typically recommend tracheostomy over non-invasive ventilation (NIV) for infants to ensure a secure airway, NIV is the only viable ventilation option provided in the list, and Option C describes the correct physiologic parameters and safety precautions relative to Option A. Thus, the item is logically valid and medically sound as a 'best answer' judgment.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-002", "question": "A term neonate develops refractory seizures on day 2 of life. The mother received isoniazid 300 mg daily throughout pregnancy for latent tuberculosis. Standard anticonvulsants have failed to control the seizures. Which of the following is the most appropriate immediate management?", "options": ["Administer pyridoxine 50 mg IV once and continue phenobarbital", "Initiate continuous video-EEG monitoring and administer pyridoxine 100 mg IV every 6 hours", "Perform emergent MRI brain to evaluate for structural lesions", "Administer pyridoxal-5-phosphate 30 mg/kg/day and discontinue all other anticonvulsants", "Obtain lumbar puncture to evaluate for meningitis before initiating specific therapy"], "answer": "B", "answer_index": 1, "explanation": "Isoniazid use during pregnancy causes pyridoxine deficiency in neonates, leading to refractory seizures that respond only to high-dose pyridoxine replacement. The diagnosis requires continuous EEG monitoring to document response to therapy, as clinical improvement may be delayed. A single 50 mg dose is insufficient, and pyridoxal-5-phosphate is the active form but not the standard initial therapy. Delaying specific therapy for imaging or LP risks ongoing seizure-induced brain injury.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a neonate with refractory seizures and a maternal history of isoniazid (INH) use, highly suggestive of INH-induced pyridoxine (Vitamin B6) deficiency. The specific antidote is pyridoxine. Key clues driving the answer are the maternal medication history and the refractory nature of the seizures. \\n\\nOption B is the best answer because the standard diagnostic and therapeutic intervention is a trial of intravenous pyridoxine (typically 100 mg). Crucially, this trial should be performed under continuous video-EEG monitoring to document the cessation of electrographic seizures, as clinical signs may uncouple from cortical activity in neonates. While the maintenance dosing in Option B ('every 6 hours') is higher than typical chronic maintenance (usually 50–100 mg/day total), the immediate priority is the 100 mg trial dose and EEG confirmation, making B superior to Option A (which lacks EEG and uses a lower, though sometimes acceptable, dose). Options C and E are appropriate for other etiologies but should not delay the administration of the specific antidote in this context. Option D refers to PLP, used for PNPO deficiency, not primary B6 deficiency/INH effects.\\n\\nMinimal fix: None required for validity, though the maintenance schedule in B could be adjusted to standard daily dosing for better precision.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette describes a neonate with refractory seizures and a maternal history of isoniazid (INH) use, highly suggestive of INH-induced pyridoxine (Vitamin B6) deficiency. The specific antidote is pyridoxine. Key clues driving the answer are the maternal medication history and the refractory nature of the seizures. \n\nOption B is the best answer because the standard diagnostic and therapeutic intervention is a trial of intravenous pyridoxine (typically 100 mg). Crucially, this trial should be performed under continuous video-EEG monitoring to document the cessation of electrographic seizures, as clinical signs may uncouple from cortical activity in neonates. While the maintenance dosing in Option B ('every 6 hours') is higher than typical chronic maintenance (usually 50–100 mg/day total), the immediate priority is the 100 mg trial dose and EEG confirmation, making B superior to Option A (which lacks EEG and uses a lower, though sometimes acceptable, dose). Options C and E are appropriate for other etiologies but should not delay the administration of the specific antidote in this context. Option D refers to PLP, used for PNPO deficiency, not primary B6 deficiency/INH effects.\n\nMinimal fix: None required for validity, though the maintenance schedule in B could be adjusted to standard daily dosing for better precision.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-003", "question": "A 4-year-old child with Williams syndrome is scheduled for cardiac catheterization to evaluate supravalvular aortic stenosis. Preoperative echocardiography demonstrates diffuse coronary artery narrowing. The child has a history of hypercalcemia managed with dietary restriction. Which anesthetic agent is most contraindicated in this patient?", "options": ["Sevoflurane due to risk of malignant hyperthermia", "Propofol due to risk of propofol infusion syndrome", "Ketamine due to risk of exacerbating hypercalcemia", "Dexmedetomidine due to risk of severe bradycardia", "Isoflurane due to risk of coronary steal phenomenon"], "answer": "E", "answer_index": 4, "explanation": "Williams syndrome patients with coronary artery stenosis are at high risk for myocardial ischemia. Isoflurane causes coronary vasodilation and can precipitate coronary steal in patients with fixed stenotic lesions, potentially causing fatal arrhythmias. While sevoflurane is generally safe, all volatile anesthetics should be used cautiously. The hypercalcemia in Williams syndrome is not exacerbated by ketamine, and dexmedetomidine-induced bradycardia is manageable. Propofol infusion syndrome is rare with single-bolus dosing.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe item is logically valid and solvable. The question asks for the agent that is 'most contraindicated' and provides a reason for each. The distractors can be eliminated because their attached reasoning is factually incorrect: Williams syndrome is not associated with Malignant Hyperthermia (Option A), and Ketamine does not exacerbate hypercalcemia (Option C). Propofol infusion syndrome (Option B) is not a risk for single-procedure anesthesia. While the clinical phenomenon of 'coronary steal' with Isoflurane is debated in modern literature, it is a classic board-exam concept associated with coronary stenosis. Given the patient's diffuse coronary narrowing, the theoretical risk of steal and the known risk of vasodilation (hypotension reducing coronary perfusion) make Option E the only choice with a plausible mechanism and correct pharmacological association in the context of board exams.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe item is logically valid and solvable. The question asks for the agent that is 'most contraindicated' and provides a reason for each. The distractors can be eliminated because their attached reasoning is factually incorrect: Williams syndrome is not associated with Malignant Hyperthermia (Option A), and Ketamine does not exacerbate hypercalcemia (Option C). Propofol infusion syndrome (Option B) is not a risk for single-procedure anesthesia. While the clinical phenomenon of 'coronary steal' with Isoflurane is debated in modern literature, it is a classic board-exam concept associated with coronary stenosis. Given the patient's diffuse coronary narrowing, the theoretical risk of steal and the known risk of vasodilation (hypotension reducing coronary perfusion) make Option E the only choice with a plausible mechanism and correct pharmacological association in the context of board exams.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-004", "question": "A 7-year-old boy with X-linked chronic granulomatous disease presents with persistent fever and right tibial pain despite broad-spectrum antibiotics. MRI demonstrates osteomyelitis. Biopsy cultures grow Aspergillus nidulans. The patient is on prophylactic interferon-gamma 50 mcg/m² three times weekly. Which of the following is the most appropriate management?", "options": ["Increase interferon-gamma to 100 mcg/m² and add voriconazole", "Discontinue interferon-gamma and initiate liposomal amphotericin B alone", "Continue interferon-gamma and initiate voriconazole with therapeutic drug monitoring", "Switch to interferon-alpha and add caspofungin", "Continue current prophylaxis and add oral itraconazole"], "answer": "C", "answer_index": 2, "explanation": "Aspergillus nidulans is uniquely virulent in CGD and requires aggressive antifungal therapy with voriconazole, which has superior activity against this species compared to amphotericin B. Interferon-gamma prophylaxis should be continued as it enhances neutrophil function and improves outcomes. Therapeutic drug monitoring is essential as CGD patients have altered voriconazole metabolism. Interferon-alpha is not used in CGD, and itraconazole has variable absorption and inferior efficacy against A. nidulans.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is medically accurate and logically sound (Validity: V). The vignette describes a classic presentation of Aspergillus nidulans osteomyelitis in a patient with Chronic Granulomatous Disease (CGD). A. nidulans is notable for its virulence in CGD and frequent resistance to amphotericin B, making voriconazole the treatment of choice due to its spectrum and superior bone penetration. Therapeutic drug monitoring (TDM) is standard for voriconazole due to non-linear pharmacokinetics and genetic variability in metabolism. Continuing interferon-gamma is the standard of care to maintain macrophage function during infection. Option A is incorrect because increasing the interferon dose is not standard initial management. Option B is incorrect due to the likely resistance of A. nidulans to amphotericin B. Options D and E offer inferior antifungal coverage and incorrect immunomodulation. The keyed answer (C) is the clear best choice.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is medically accurate and logically sound (Validity: V). The vignette describes a classic presentation of Aspergillus nidulans osteomyelitis in a patient with Chronic Granulomatous Disease (CGD). A. nidulans is notable for its virulence in CGD and frequent resistance to amphotericin B, making voriconazole the treatment of choice due to its spectrum and superior bone penetration. Therapeutic drug monitoring (TDM) is standard for voriconazole due to non-linear pharmacokinetics and genetic variability in metabolism. Continuing interferon-gamma is the standard of care to maintain macrophage function during infection. Option A is incorrect because increasing the interferon dose is not standard initial management. Option B is incorrect due to the likely resistance of A. nidulans to amphotericin B. Options D and E offer inferior antifungal coverage and incorrect immunomodulation. The keyed answer (C) is the clear best choice.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-005", "question": "A 2-month-old infant presents with delayed separation of the umbilical cord (>3 weeks), severe leukocytosis (WBC 80,000), and recurrent skin infections. Flow cytometry shows absent CD18 expression. Genetic testing confirms ITGB2 mutation. Which of the following is the most appropriate management?", "options": ["Initiate prophylactic antibiotics and schedule stem cell transplant after 1 year of age", "Perform urgent stem cell transplant before onset of severe infections", "Initiate granulocyte colony-stimulating factor and delay transplant until 5 years of age", "Treat infections as they occur and consider transplant only if infections become life-threatening", "Initiate prophylactic interferon-gamma and schedule transplant during adolescence"], "answer": "B", "answer_index": 1, "explanation": "Leukocyte adhesion deficiency type I is a severe immunodeficiency with absent CD18 leading to defective neutrophil adhesion and migration. The prognosis is poor without stem cell transplantation, with most patients dying before age 2 from severe infections. Urgent transplant before the onset of life-threatening infections offers the best survival. Delaying transplant beyond infancy is associated with significantly worse outcomes due to cumulative infectious complications and organ damage. G-CSF and interferon-gamma do not correct the underlying defect.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of severe Leukocyte Adhesion Deficiency Type 1 (LAD-1), confirmed by delayed umbilical cord separation, extreme leukocytosis, and absent CD18 (ITGB2 mutation). The severe phenotype (absent CD18) is associated with extremely high mortality in infancy (often before age 2) due to overwhelming infection. Hematopoietic stem cell transplantation (HSCT) is the only curative therapy. The standard of care for severe LAD-1 is early HSCT, ideally performed before the onset of severe complications or significant organ damage. Therefore, Option B is the correct best answer. Option A is incorrect because delaying transplant until after 1 year significantly increases the risk of fatal infection in this severe phenotype. Option C is incorrect because delaying until age 5 is unsafe, and G-CSF does not correct the functional adhesion defect. Option E suggests treatment for Chronic Granulomatous Disease (IFN-gamma) and an inappropriate timeline. The item is medically accurate, discriminates well based on disease severity and prognosis, and contains no logical flaws.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of severe Leukocyte Adhesion Deficiency Type 1 (LAD-1), confirmed by delayed umbilical cord separation, extreme leukocytosis, and absent CD18 (ITGB2 mutation). The severe phenotype (absent CD18) is associated with extremely high mortality in infancy (often before age 2) due to overwhelming infection. Hematopoietic stem cell transplantation (HSCT) is the only curative therapy. The standard of care for severe LAD-1 is early HSCT, ideally performed before the onset of severe complications or significant organ damage. Therefore, Option B is the correct best answer. Option A is incorrect because delaying transplant until after 1 year significantly increases the risk of fatal infection in this severe phenotype. Option C is incorrect because delaying until age 5 is unsafe, and G-CSF does not correct the functional adhesion defect. Option E suggests treatment for Chronic Granulomatous Disease (IFN-gamma) and an inappropriate timeline. The item is medically accurate, discriminates well based on disease severity and prognosis, and contains no logical flaws.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-006", "question": "A 5-year-old boy with King-Denborough syndrome (dysmorphic facies, congenital myopathy, cryptorchidism) is scheduled for inguinal hernia repair. The patient has a known RYR1 mutation. Which of the following is the most appropriate anesthetic plan?", "options": ["Use total intravenous anesthesia with propofol and remifentanil, avoid dantrolene prophylaxis", "Administer dantrolene 2.5 mg/kg IV preoperatively and use sevoflurane", "Use regional anesthesia alone with spinal block, have dantrolene immediately available", "Administer dantrolene 5 mg/kg IV preoperatively and avoid all volatile agents", "Use desflurane with dantrolene 2.5 mg/kg prophylaxis"], "answer": "C", "answer_index": 2, "explanation": "King-Denborough syndrome is associated with malignant hyperthermia susceptibility due to RYR1 mutations. However, prophylactic dantrolene is not recommended due to its own side effects. Regional anesthesia is the preferred technique when feasible, avoiding triggers entirely. If general anesthesia is necessary, total intravenous anesthesia is preferred with dantrolene immediately available, not administered prophylactically. All volatile agents are contraindicated in known MH-susceptible patients.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient has King-Denborough syndrome and an RYR1 mutation, indicating susceptibility to Malignant Hyperthermia (MH). The anesthetic plan must avoid triggers (volatile agents, succinylcholine). Options B and E suggest using volatile agents (sevoflurane, desflurane), which are contraindicated. Option D suggests prophylactic dantrolene, which is no longer recommended due to side effects, making it incorrect. This leaves Options A and C. Option A (TIVA with propofol/remifentanil, no prophylaxis) is the standard of care for a 5-year-old MHS patient, as it is non-triggering and appropriate for the patient's age. Option C (Regional anesthesia alone) is theoretically safe regarding MH but clinically inappropriate for a 5-year-old undergoing inguinal hernia repair; children of this age typically cannot tolerate surgery under regional blockade without deep sedation or general anesthesia. While regional is preferred 'when feasible' (as the rationale states), it is not feasible 'alone' in this vignette. Therefore, Option A is the clear best answer clinically, but the item is keyed as C. This constitutes a miskeyed item where the author prioritized a theoretical MH hierarchy over pediatric anesthesia standards.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient has King-Denborough syndrome and an RYR1 mutation, indicating susceptibility to Malignant Hyperthermia (MH). The anesthetic plan must avoid triggers (volatile agents, succinylcholine). Options B and E suggest using volatile agents (sevoflurane, desflurane), which are contraindicated. Option D suggests prophylactic dantrolene, which is no longer recommended due to side effects, making it incorrect. This leaves Options A and C. Option A (TIVA with propofol/remifentanil, no prophylaxis) is the standard of care for a 5-year-old MHS patient, as it is non-triggering and appropriate for the patient's age. Option C (Regional anesthesia alone) is theoretically safe regarding MH but clinically inappropriate for a 5-year-old undergoing inguinal hernia repair; children of this age typically cannot tolerate surgery under regional blockade without deep sedation or general anesthesia. While regional is preferred 'when feasible' (as the rationale states), it is not feasible 'alone' in this vignette. Therefore, Option A is the clear best answer clinically, but the item is keyed as C. This constitutes a miskeyed item where the author prioritized a theoretical MH hierarchy over pediatric anesthesia standards.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-007", "question": "A 32-year-old G2P1 at 34 weeks gestation presents with severe preeclampsia, HELLP syndrome, and acute decompensated peripartum cardiomyopathy (EF 25%). She is started on bromocriptine 2.5 mg twice daily to inhibit lactation. Emergency cesarean delivery is indicated. Which anesthetic technique is most appropriate?", "options": ["General anesthesia with etomidate and low-dose sevoflurane", "Spinal anesthesia with hyperbaric bupivacaine 12 mg", "Epidural anesthesia with slow titration of local anesthetic", "General anesthesia with ketamine and high-dose sevoflurane", "Local infiltration anesthesia with monitored anesthesia care"], "answer": "C", "answer_index": 2, "explanation": "Bromocriptine, a dopamine D2 agonist, can cause severe vasoconstriction and hypertensive crises, particularly when combined with general anesthetic agents. Neuraxial anesthesia (epidural) is preferred in peripartum cardiomyopathy to avoid hemodynamic fluctuations. Slow titration of epidural anesthesia allows for gradual onset and better hemodynamic stability compared to spinal anesthesia, which can cause abrupt sympathectomy and cardiovascular collapse. General anesthesia should be avoided due to the risk of bromocriptine-induced hypertension and myocardial depression.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is logically flawed and medically underspecified. First, the patient has HELLP syndrome, which is defined in part by thrombocytopenia (low platelets). The stem fails to provide a platelet count; without this, it is impossible to determine if neuraxial anesthesia (Option C) is safe or contraindicated (risk of epidural hematoma). If platelets are <75,000/µL, General Anesthesia (Option A) would be the standard of care despite cardiac risks. Second, the stem specifies 'Emergency' cesarean delivery, which implies an immediate threat requiring rapid delivery. Option C ('slow titration' of epidural) is temporally incompatible with a true emergency; GA is the standard for crash sections when no epidural is in place. Third, the use of bromocriptine in an antepartum patient with active severe preeclampsia is controversial and often contraindicated due to the risk of hypertensive crisis/stroke, making the premise medically questionable. The rationale relies on a niche drug interaction to force Option C, ignoring the primary coagulopathy and timing constraints. A platelet count and clarification of urgency are required to make the answer defensible.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically flawed and medically underspecified. First, the patient has HELLP syndrome, which is defined in part by thrombocytopenia (low platelets). The stem fails to provide a platelet count; without this, it is impossible to determine if neuraxial anesthesia (Option C) is safe or contraindicated (risk of epidural hematoma). If platelets are <75,000/µL, General Anesthesia (Option A) would be the standard of care despite cardiac risks. Second, the stem specifies 'Emergency' cesarean delivery, which implies an immediate threat requiring rapid delivery. Option C ('slow titration' of epidural) is temporally incompatible with a true emergency; GA is the standard for crash sections when no epidural is in place. Third, the use of bromocriptine in an antepartum patient with active severe preeclampsia is controversial and often contraindicated due to the risk of hypertensive crisis/stroke, making the premise medically questionable. The rationale relies on a niche drug interaction to force Option C, ignoring the primary coagulopathy and timing constraints. A platelet count and clarification of urgency are required to make the answer defensible.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-008", "question": "A 28-year-old Ashkenazi Jewish man develops progressive gait ataxia, dysarthria, and treatment-resistant psychosis with visual hallucinations. Hexosaminidase A activity is 5% of normal. MRI shows cerebellar atrophy. Which of the following is the most appropriate management?", "options": ["Initiate antipsychotic therapy with clozapine and refer for genetic counseling", "Enroll in clinical trial of miglustat substrate reduction therapy", "Initiate intrathecal enzyme replacement therapy with recombinant hexosaminidase A", "Prescribe donepezil for cognitive symptoms and risperidone for psychosis", "Recommend palliative care as no disease-modifying therapy exists"], "answer": "B", "answer_index": 1, "explanation": "Late-onset Tay-Sachs disease (LOTS) is a GM2 gangliosidosis with residual hexosaminidase A activity. While there is no FDA-approved therapy, miglustat has shown promise in clinical trials for substrate reduction. Intrathecal enzyme replacement is experimental and not widely available. Standard antipsychotics treat symptoms but not the underlying disease. Palliative care is premature as disease-modifying trials are ongoing.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: Miskeyed; Option A is the best answer. The patient has Late-Onset Tay-Sachs (LOTS) disease, characterized by cerebellar ataxia and psychiatric symptoms in an Ashkenazi Jewish adult with low Hexosaminidase A. The stem describes 'treatment-resistant psychosis,' a hallmark of LOTS. The medical standard of care for psychosis in LOTS is clozapine, as these patients are often resistant to other antipsychotics and prone to extrapyramidal side effects (making Option A correct). Option B suggests miglustat; while theoretically a substrate reduction therapy, randomized controlled trials in LOTS failed to show significant clinical benefit, and it is not FDA-approved for this indication. Prioritizing enrollment in a trial for a drug with negative/equivocal evidence over the established drug of choice for the patient's severe active symptoms (psychosis) is clinically incorrect. Thus, A is the clear best answer, but the key is B.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: Miskeyed; Option A is the best answer. The patient has Late-Onset Tay-Sachs (LOTS) disease, characterized by cerebellar ataxia and psychiatric symptoms in an Ashkenazi Jewish adult with low Hexosaminidase A. The stem describes 'treatment-resistant psychosis,' a hallmark of LOTS. The medical standard of care for psychosis in LOTS is clozapine, as these patients are often resistant to other antipsychotics and prone to extrapyramidal side effects (making Option A correct). Option B suggests miglustat; while theoretically a substrate reduction therapy, randomized controlled trials in LOTS failed to show significant clinical benefit, and it is not FDA-approved for this indication. Prioritizing enrollment in a trial for a drug with negative/equivocal evidence over the established drug of choice for the patient's severe active symptoms (psychosis) is clinically incorrect. Thus, A is the clear best answer, but the key is B.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-009", "question": "A 22-year-old man with schizophrenia has required risperidone 24 mg daily (8 times the standard dose) to achieve therapeutic response. Genetic testing reveals CYP2D6 ultrarapid metabolizer status (gene duplication). Which of the following monitoring parameters is most critical?", "options": ["Weekly complete blood count for agranulocytosis", "Quarterly fasting glucose and lipid panel", "Monthly prolactin level", "Baseline and annual QTc interval monitoring", "Weekly liver function tests"], "answer": "D", "answer_index": 3, "explanation": "CYP2D6 ultrarapid metabolism leads to extremely high doses of risperidone being required, resulting in accumulation of the active metabolite 9-hydroxyrisperidone. This significantly increases the risk of dose-dependent QTc prolongation and torsades de pointes. While metabolic monitoring is important, QTc prolongation is the most immediate life-threatening risk at these supratherapeutic doses. Agranulocytosis is associated with clozapine, not risperidone.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item presents a clinical scenario of a patient requiring a supratherapeutic dose (24 mg) of risperidone due to CYP2D6 ultrarapid metabolism. The question asks for the most critical monitoring parameter. \\n\\n1.  **Clinical Logic**: Risperidone is metabolized to 9-hydroxyrisperidone (paliperidone). In ultrarapid metabolizers, conversion is extensive. While the patient achieves therapeutic response (implying efficacy), the absolute load of active moiety (parent + metabolite) at 24 mg is very high. High doses of antipsychotics are associated with dose-dependent QTc prolongation, a risk factor for Torsades de Pointes (sudden cardiac death).\\n2.  **Option Analysis**: \\n    *   A (CBC): Specific to Clozapine, not Risperidone.\\n    *   B (Glucose/Lipids): Important for long-term health (metabolic syndrome) but less immediately critical than cardiac arrhythmia risks; also, standard guidelines suggest annual monitoring after the first year, not quarterly, unless indicated.\\n    *   C (Prolactin): Risperidone causes hyperprolactinemia, but monitoring is typically symptom-driven, not routine monthly.\\n    *   E (LFTs): Not a primary concern.\\n    *   D (QTc): Represents the most significant mortality risk associated with massive overdose/supratherapeutic dosing. \\n3.  **Validity**: The item is logically sound. The distinction between long-term morbidity (metabolic) and potential mortality (cardiac) defines the 'most critical' answer.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item presents a clinical scenario of a patient requiring a supratherapeutic dose (24 mg) of risperidone due to CYP2D6 ultrarapid metabolism. The question asks for the most critical monitoring parameter. \n\n1.  **Clinical Logic**: Risperidone is metabolized to 9-hydroxyrisperidone (paliperidone). In ultrarapid metabolizers, conversion is extensive. While the patient achieves therapeutic response (implying efficacy), the absolute load of active moiety (parent + metabolite) at 24 mg is very high. High doses of antipsychotics are associated with dose-dependent QTc prolongation, a risk factor for Torsades de Pointes (sudden cardiac death).\n2.  **Option Analysis**: \n    *   A (CBC): Specific to Clozapine, not Risperidone.\n    *   B (Glucose/Lipids): Important for long-term health (metabolic syndrome) but less immediately critical than cardiac arrhythmia risks; also, standard guidelines suggest annual monitoring after the first year, not quarterly, unless indicated.\n    *   C (Prolactin): Risperidone causes hyperprolactinemia, but monitoring is typically symptom-driven, not routine monthly.\n    *   E (LFTs): Not a primary concern.\n    *   D (QTc): Represents the most significant mortality risk associated with massive overdose/supratherapeutic dosing. \n3.  **Validity**: The item is logically sound. The distinction between long-term morbidity (metabolic) and potential mortality (cardiac) defines the 'most critical' answer.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-010", "question": "A 19-year-old woman presents with 2 weeks of progressive psychosis, culminating in nihilistic delusions that she is dead and her organs are rotting (Cotard's syndrome). CSF analysis reveals anti-NMDA receptor antibodies. Which of the following is the most appropriate initial treatment?", "options": ["High-dose oral antipsychotics and psychiatric admission", "Intravenous immunoglobulin 2 g/kg and high-dose corticosteroids", "Electroconvulsive therapy for refractory psychosis", "Plasmapheresis alone", "Rituximab monotherapy"], "answer": "B", "answer_index": 1, "explanation": "NMDA receptor encephalitis is a treatable autoimmune encephalitis that frequently presents with severe psychiatric symptoms including Cotard's syndrome. First-line immunotherapy with IVIG and high-dose corticosteroids is essential and should not be delayed for psychiatric treatment alone. ECT has no role in the acute autoimmune phase. Plasmapheresis alone is less effective than combination therapy, and rituximab is reserved for refractory cases after first-line therapy.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a confirmed case of anti-NMDA receptor encephalitis (psychosis, Cotard's, positive CSF antibodies). The standard of care for initial management is immunotherapy (and tumor removal if applicable). First-line immunotherapy typically involves corticosteroids, IVIG, or plasma exchange (PLEX). Option B (IVIG and high-dose corticosteroids) represents a standard, widely accepted first-line regimen. Option A is incorrect because antipsychotics treat symptoms, not the underlying autoimmune cause, and patients with NMDAR encephalitis have increased sensitivity to neuroleptic malignant syndrome. Option E (Rituximab) is a second-line therapy reserved for treatment failure. Option C (ECT) may be used for severe catatonia but is not the primary disease-modifying treatment. Option D (Plasmapheresis alone) is a valid modality, but Option B is the 'best' answer as it combines two first-line agents (steroids + IVIG), which is a common and robust initial approach compared to PLEX monotherapy without steroids. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a confirmed case of anti-NMDA receptor encephalitis (psychosis, Cotard's, positive CSF antibodies). The standard of care for initial management is immunotherapy (and tumor removal if applicable). First-line immunotherapy typically involves corticosteroids, IVIG, or plasma exchange (PLEX). Option B (IVIG and high-dose corticosteroids) represents a standard, widely accepted first-line regimen. Option A is incorrect because antipsychotics treat symptoms, not the underlying autoimmune cause, and patients with NMDAR encephalitis have increased sensitivity to neuroleptic malignant syndrome. Option E (Rituximab) is a second-line therapy reserved for treatment failure. Option C (ECT) may be used for severe catatonia but is not the primary disease-modifying treatment. Option D (Plasmapheresis alone) is a valid modality, but Option B is the 'best' answer as it combines two first-line agents (steroids + IVIG), which is a common and robust initial approach compared to PLEX monotherapy without steroids. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-011", "question": "A 14-year-old girl with short stature, obesity, and developmental delay presents with seizures. Labs show hypocalcemia (6.8 mg/dL), hyperphosphatemia, and elevated PTH (250 pg/mL). She has brachydactyly and subcutaneous calcifications. Which of the following is the most appropriate diagnostic test?", "options": ["GNAS gene sequencing for activating mutations", "Methylation-specific PCR of the GNAS locus", "Calcium-sensing receptor gene analysis", "Vitamin D 25-hydroxy level", "Thyroid function tests"], "answer": "B", "answer_index": 1, "explanation": "Pseudohypoparathyroidism type 1A is caused by maternally inherited inactivating mutations in GNAS with loss of imprinting. The diagnosis requires methylation-specific PCR to demonstrate abnormal GNAS methylation patterns, which distinguishes it from other forms of PHP and from pseudopseudohypoparathyroidism. Standard gene sequencing alone is insufficient as it doesn't assess imprinting. The biochemical pattern (elevated PTH with hypocalcemia) is characteristic of PTH resistance.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic case of Pseudohypoparathyroidism type 1A (PHP1A), characterized by the combination of Albright Hereditary Osteodystrophy (AHO) features (short stature, obesity, brachydactyly, subcutaneous calcifications) and end-organ resistance to PTH (hypocalcemia, hyperphosphatemia, elevated PTH). The gold standard diagnostic test for PHP1A is *GNAS* gene sequencing to identify a heterozygous inactivating mutation on the maternal allele. Option A is incorrect because it specifies 'activating' mutations, which cause McCune-Albright syndrome, not PHP. Option B (Methylation-specific PCR) is the primary diagnostic test for PHP1B, which involves imprinting defects and typically lacks the AHO phenotype. In PHP1A, the methylation pattern at the *GNAS* locus is usually normal; the disease is caused by a coding sequence mutation. The provided explanation incorrectly states that methylation analysis is required for PHP1A and that sequencing is insufficient. Furthermore, it falsely claims methylation distinguishes PHP1A from Pseudopseudohypoparathyroidism (PPHP); in reality, both share the same mutation, and the distinction is clinical or based on parental origin. Since Option A cites the wrong mechanism ('activating') and Option B is the wrong test for the described subtype, no correct answer is provided.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic case of Pseudohypoparathyroidism type 1A (PHP1A), characterized by the combination of Albright Hereditary Osteodystrophy (AHO) features (short stature, obesity, brachydactyly, subcutaneous calcifications) and end-organ resistance to PTH (hypocalcemia, hyperphosphatemia, elevated PTH). The gold standard diagnostic test for PHP1A is *GNAS* gene sequencing to identify a heterozygous inactivating mutation on the maternal allele. Option A is incorrect because it specifies 'activating' mutations, which cause McCune-Albright syndrome, not PHP. Option B (Methylation-specific PCR) is the primary diagnostic test for PHP1B, which involves imprinting defects and typically lacks the AHO phenotype. In PHP1A, the methylation pattern at the *GNAS* locus is usually normal; the disease is caused by a coding sequence mutation. The provided explanation incorrectly states that methylation analysis is required for PHP1A and that sequencing is insufficient. Furthermore, it falsely claims methylation distinguishes PHP1A from Pseudopseudohypoparathyroidism (PPHP); in reality, both share the same mutation, and the distinction is clinical or based on parental origin. Since Option A cites the wrong mechanism ('activating') and Option B is the wrong test for the described subtype, no correct answer is provided.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-012", "question": "A 4-year-old boy with newly diagnosed high-risk T-cell ALL develops tumor lysis syndrome with uric acid 12 mg/dL and creatinine 2.5 mg/dL. He is found to have G6PD deficiency. Which of the following is the most appropriate management?", "options": ["Administer rasburicase 0.2 mg/kg IV daily", "Initiate aggressive hydration and allopurinol, avoid rasburicase", "Perform emergent hemodialysis", "Administer rasburicase 0.1 mg/kg with concurrent blood transfusion", "Initiate alkalinization of urine to pH >7.5"], "answer": "B", "answer_index": 1, "explanation": "Rasburicase is contraindicated in G6PD deficiency as it can precipitate severe hemolysis by generating hydrogen peroxide. In G6PD-deficient patients with tumor lysis syndrome, aggressive hydration and allopurinol are the mainstays of therapy. Hemodialysis is reserved for refractory cases. Alkalinization is no longer routinely recommended due to risk of calcium phosphate precipitation. The risk of hemolysis outweighs the benefits of rasburicase in this population.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). \\nVerdict: Correct best answer. \\nThe item correctly tests the management of Tumor Lysis Syndrome (TLS) in the context of a specific contraindication. Rasburicase is the standard of care for high-risk TLS (uric acid > 8 mg/dL) but is contraindicated in G6PD deficiency due to the risk of severe hemolysis and methemoglobinemia (hydrogen peroxide production). Therefore, Options A and D are incorrect. Urinary alkalinization (Option E) is no longer recommended due to the risk of calcium phosphate precipitation. \\n\\nThe choice between Option B (hydration/allopurinol) and Option C (dialysis) is the main discriminator. While the patient has severe AKI (Cr 2.5 mg/dL in a 4-year-old), dialysis is typically reserved for refractory hyperkalemia, volume overload, or failure of medical management. Despite the high uric acid, initiating aggressive hydration and allopurinol is the standard first-line medical alternative when rasburicase cannot be used. Option B explicitly mentions avoiding the contraindicated drug, reinforcing the teaching point. The item is medically accurate and logically sound for a board-style exam.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). \nVerdict: Correct best answer. \nThe item correctly tests the management of Tumor Lysis Syndrome (TLS) in the context of a specific contraindication. Rasburicase is the standard of care for high-risk TLS (uric acid > 8 mg/dL) but is contraindicated in G6PD deficiency due to the risk of severe hemolysis and methemoglobinemia (hydrogen peroxide production). Therefore, Options A and D are incorrect. Urinary alkalinization (Option E) is no longer recommended due to the risk of calcium phosphate precipitation. \n\nThe choice between Option B (hydration/allopurinol) and Option C (dialysis) is the main discriminator. While the patient has severe AKI (Cr 2.5 mg/dL in a 4-year-old), dialysis is typically reserved for refractory hyperkalemia, volume overload, or failure of medical management. Despite the high uric acid, initiating aggressive hydration and allopurinol is the standard first-line medical alternative when rasburicase cannot be used. Option B explicitly mentions avoiding the contraindicated drug, reinforcing the teaching point. The item is medically accurate and logically sound for a board-style exam.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-013", "question": "A 6-year-old boy has significant difficulties with social communication, including inappropriate responses in conversation and difficulty understanding non-literal language. He does not have restricted interests or repetitive behaviors. Which assessment tool is most appropriate to differentiate Social Communication Disorder from autism spectrum disorder?", "options": ["Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)", "Social Communication Questionnaire (SCQ)", "Children's Communication Checklist (CCC-2)", "Social Responsiveness Scale (SRS)", "Gilliam Autism Rating Scale (GARS)"], "answer": "C", "answer_index": 2, "explanation": "The Children's Communication Checklist-2 specifically evaluates pragmatic language skills and social communication deficits while distinguishing these from restricted/repetitive behaviors characteristic of autism. The ADOS-2 and SCQ are designed to identify autism, not to differentiate SCD from ASD. The SRS measures social impairment but doesn't assess the full diagnostic criteria distinction. GARS is a screening tool for autism, not a differential diagnostic instrument.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a child with social communication deficits but without restricted, repetitive behaviors (RRBs), consistent with Social Communication Disorder (SCD). The question asks for the tool best suited to differentiate SCD from Autism Spectrum Disorder (ASD). The Children's Communication Checklist-2 (CCC-2) is widely recognized as the specific instrument for assessing pragmatic language impairment (the core deficit in SCD) and distinguishing it from structural language disorders and ASD. While the ADOS-2 (Option A) is the gold standard for diagnosing ASD, it is primarily a diagnostic algorithm for autism; if a child lacks RRBs, they simply do not meet ASD criteria on the ADOS, but the tool itself is not specifically 'normed' to diagnose SCD as a positive finding in the same way the CCC-2 profiles pragmatic deficits. The CCC-2 specifically isolates pragmatic difficulties. Therefore, Option C is the standard board-exam answer for assessing pragmatic language/SCD. The item is logically sound and medically accurate within the context of standardized testing.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a child with social communication deficits but without restricted, repetitive behaviors (RRBs), consistent with Social Communication Disorder (SCD). The question asks for the tool best suited to differentiate SCD from Autism Spectrum Disorder (ASD). The Children's Communication Checklist-2 (CCC-2) is widely recognized as the specific instrument for assessing pragmatic language impairment (the core deficit in SCD) and distinguishing it from structural language disorders and ASD. While the ADOS-2 (Option A) is the gold standard for diagnosing ASD, it is primarily a diagnostic algorithm for autism; if a child lacks RRBs, they simply do not meet ASD criteria on the ADOS, but the tool itself is not specifically 'normed' to diagnose SCD as a positive finding in the same way the CCC-2 profiles pragmatic deficits. The CCC-2 specifically isolates pragmatic difficulties. Therefore, Option C is the standard board-exam answer for assessing pragmatic language/SCD. The item is logically sound and medically accurate within the context of standardized testing.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-014", "question": "A 3-year-old boy of Palestinian descent presents with chronic multifocal osteomyelitis, dyserythropoietic anemia, and neutrophilic dermatosis. Genetic testing reveals LPIN2 mutation (Majeed syndrome). Which NSAID is most effective for long-term management?", "options": ["Ibuprofen 10 mg/kg every 6 hours", "Naproxen 5 mg/kg twice daily", "Indomethacin 1-2 mg/kg/day in divided doses", "Celecoxib 50 mg twice daily", "Aspirin 10 mg/kg every 4 hours"], "answer": "C", "answer_index": 2, "explanation": "Majeed syndrome is an autoinflammatory disease characterized by chronic recurrent multifocal osteomyelitis. Indomethacin is the NSAID of choice due to its potent anti-inflammatory effects and superior efficacy in autoinflammatory bone diseases compared to other NSAIDs. The response to indomethacin can also serve as a diagnostic clue. Other NSAIDs are less effective, and aspirin should be avoided in children due to Reye syndrome risk. COX-2 inhibitors have limited data in this rare condition.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible). \\nVerdict: Multiple defensible answers (Naproxen vs. Indomethacin). \\nThe vignette describes Majeed syndrome (CRMO, dyserythropoietic anemia, neutrophilic dermatosis). While NSAIDs are the first-line treatment for the CRMO component, the choice between Indomethacin (C) and Naproxen (B) is not distinct enough to support a single best answer. Indomethacin is historically considered a potent NSAID for bone inflammation, but Naproxen is the standard first-line agent in pediatric rheumatology for long-term management of CRMO due to its superior safety profile and convenient dosing. Indomethacin carries significant risks of GI toxicity and headache, making it less ideal for 'long-term management' in a 3-year-old unless the patient fails Naproxen. Option B provides a therapeutic (albeit low-end) dose of Naproxen. Consequently, both B (standard of care) and C (historical potency) are defensible. The item relies on older dogma regarding Indomethacin's superiority which is not universally accepted in modern pediatric practice where IL-1 inhibitors are used for severe cases.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible). \nVerdict: Multiple defensible answers (Naproxen vs. Indomethacin). \nThe vignette describes Majeed syndrome (CRMO, dyserythropoietic anemia, neutrophilic dermatosis). While NSAIDs are the first-line treatment for the CRMO component, the choice between Indomethacin (C) and Naproxen (B) is not distinct enough to support a single best answer. Indomethacin is historically considered a potent NSAID for bone inflammation, but Naproxen is the standard first-line agent in pediatric rheumatology for long-term management of CRMO due to its superior safety profile and convenient dosing. Indomethacin carries significant risks of GI toxicity and headache, making it less ideal for 'long-term management' in a 3-year-old unless the patient fails Naproxen. Option B provides a therapeutic (albeit low-end) dose of Naproxen. Consequently, both B (standard of care) and C (historical potency) are defensible. The item relies on older dogma regarding Indomethacin's superiority which is not universally accepted in modern pediatric practice where IL-1 inhibitors are used for severe cases.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-015", "question": "A 2-year-old toddler ingests a 0.3 mg clonidine transdermal patch. Six hours later, he becomes lethargic with bradycardia (HR 60) and hypotension (BP 70/40). Which of the following is the most appropriate management?", "options": ["Administer activated charcoal and observe", "Initiate atropine 0.02 mg/kg IV for bradycardia", "Administer naloxone 0.1 mg/kg IV bolus followed by continuous infusion", "Initiate dopamine infusion at 5 mcg/kg/min", "Perform gastric lavage and administer whole bowel irrigation"], "answer": "C", "answer_index": 2, "explanation": "Clonidine toxicity causes central alpha-2 agonist-mediated CNS depression and sympathetic outflow inhibition. Naloxone competitively displaces clonidine from opioid receptors, reversing both respiratory depression and hemodynamic instability. A continuous infusion is often required due to clonidine's long half-life. Atropine may not effectively counteract the central mechanism of bradycardia. Activated charcoal is ineffective after 6 hours, and dopamine treats symptoms but not the underlying toxicity.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a classic presentation of clonidine toxicity (central alpha-2 agonist) mimicking an opioid toxidrome (lethargy, bradycardia, hypotension, miosis). The item tests the specific toxicological 'pearl' that high-dose naloxone can reverse clonidine toxicity. \\n\\nLogically, the item is valid. While the primary treatment for hypotension is IV fluids (not listed), Naloxone (Option C) is a recognized antidotal adjunct specifically for this ingestion, making it the best choice among the provided options. Dopamine (Option D) is a second-line vasopressor (indicated only after fluids), and Atropine (Option B) is often ineffective for central alpha-2 mediated bradycardia. Option E is unsafe in a lethargic child without airway protection.\\n\\nMedically, however, the provided rationale contains a significant mechanism error. It states naloxone 'competitively displaces clonidine from opioid receptors.' This is false; clonidine is an alpha-2 adrenergic agonist, not an opioid agonist. Naloxone's reversal effect is functional/physiologic (likely involving endogenous opioid modulation), not direct competitive displacement at the opioid receptor. Additionally, naloxone is inconsistent for reversing hemodynamic instability (~50% response), so relying on it as the sole management for hypotension is clinically debatable, though acceptable in the context of a 'best answer' exam item excluding fluids.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a classic presentation of clonidine toxicity (central alpha-2 agonist) mimicking an opioid toxidrome (lethargy, bradycardia, hypotension, miosis). The item tests the specific toxicological 'pearl' that high-dose naloxone can reverse clonidine toxicity. \n\nLogically, the item is valid. While the primary treatment for hypotension is IV fluids (not listed), Naloxone (Option C) is a recognized antidotal adjunct specifically for this ingestion, making it the best choice among the provided options. Dopamine (Option D) is a second-line vasopressor (indicated only after fluids), and Atropine (Option B) is often ineffective for central alpha-2 mediated bradycardia. Option E is unsafe in a lethargic child without airway protection.\n\nMedically, however, the provided rationale contains a significant mechanism error. It states naloxone 'competitively displaces clonidine from opioid receptors.' This is false; clonidine is an alpha-2 adrenergic agonist, not an opioid agonist. Naloxone's reversal effect is functional/physiologic (likely involving endogenous opioid modulation), not direct competitive displacement at the opioid receptor. Additionally, naloxone is inconsistent for reversing hemodynamic instability (~50% response), so relying on it as the sole management for hypotension is clinically debatable, though acceptable in the context of a 'best answer' exam item excluding fluids.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-016", "question": "A 6-year-old girl with Freeman-Sheldon syndrome (whistling face syndrome) requires anesthesia for tendon release surgery. She has microstomia, micrognathia, and a short neck. Which airway management strategy is most appropriate?", "options": ["Awake fiberoptic intubation with nasal approach", "Inhalational induction with sevoflurane followed by video laryngoscopy", "Intravenous induction with propofol and direct laryngoscopy", "Use of laryngeal mask airway without intubation", "Perform tracheostomy under local anesthesia before surgery"], "answer": "A", "answer_index": 0, "explanation": "Freeman-Sheldon syndrome is associated with severe facial contractures, microstomia, and limited neck extension, making mask ventilation and intubation extremely difficult. Awake fiberoptic intubation is the gold standard to secure the airway before induction of anesthesia. Inhalational induction risks airway obstruction in a patient who cannot be bag-mask ventilated effectively. Direct laryngoscopy is likely to fail due to limited mouth opening and neck mobility. LMA placement is challenging due to facial contractures.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic difficult airway scenario (Freeman-Sheldon syndrome) characterized by severe microstomia ('whistling face') and micrognathia. These features predict difficult mask ventilation and difficult laryngoscopy. Additionally, Freeman-Sheldon syndrome is historically associated with Malignant Hyperthermia (MH) susceptibility (though genetic links to MYH3 vs RYR1 are nuanced, board exams typically treat it as an MH risk). \\n\\nOption A is the keyed answer. While 'Awake' fiberoptic intubation is the theoretical gold standard for securing a known difficult airway, it is practically extremely difficult in a 6-year-old due to lack of cooperation. However, it is the only option that avoids the lethal risks of the alternatives. Option B (Sevoflurane) is contraindicated due to MH risk and the risk of airway collapse in a 'cannot mask' scenario. Option C (IV induction) risks a 'Can't Intubate, Can't Ventilate' (CICV) crisis. Option D (LMA) is likely impossible due to microstomia. Option E is overly invasive. \\n\\nDespite the practical implausibility of a truly 'awake' procedure in a 6-year-old, Option A is the only defensible choice by elimination of unsafe alternatives. The item is logically valid but medically imperfect regarding pediatric cooperation.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic difficult airway scenario (Freeman-Sheldon syndrome) characterized by severe microstomia ('whistling face') and micrognathia. These features predict difficult mask ventilation and difficult laryngoscopy. Additionally, Freeman-Sheldon syndrome is historically associated with Malignant Hyperthermia (MH) susceptibility (though genetic links to MYH3 vs RYR1 are nuanced, board exams typically treat it as an MH risk). \n\nOption A is the keyed answer. While 'Awake' fiberoptic intubation is the theoretical gold standard for securing a known difficult airway, it is practically extremely difficult in a 6-year-old due to lack of cooperation. However, it is the only option that avoids the lethal risks of the alternatives. Option B (Sevoflurane) is contraindicated due to MH risk and the risk of airway collapse in a 'cannot mask' scenario. Option C (IV induction) risks a 'Can't Intubate, Can't Ventilate' (CICV) crisis. Option D (LMA) is likely impossible due to microstomia. Option E is overly invasive. \n\nDespite the practical implausibility of a truly 'awake' procedure in a 6-year-old, Option A is the only defensible choice by elimination of unsafe alternatives. The item is logically valid but medically imperfect regarding pediatric cooperation.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-017", "question": "A 45-year-old woman on methadone 120 mg daily for chronic pain develops torsades de pointes with QTc 580 ms. She is hemodynamically unstable. Which medication is most appropriate for acute management?", "options": ["Amiodarone 150 mg IV bolus", "Magnesium sulfate 2 g IV bolus", "Isoproterenol infusion", "Lidocaine 1 mg/kg IV bolus", "Procainamide 15 mg/kg IV infusion"], "answer": "C", "answer_index": 2, "explanation": "Torsades de pointes in acquired long QT syndrome is a pause-dependent arrhythmia. Isoproterenol increases heart rate, shortening the QT interval and preventing the short-long RR interval sequence that precipitates TdP. While magnesium is first-line for stable TdP, isoproterenol is preferred in hemodynamically unstable patients. Amiodarone and procainamide further prolong the QT interval and are contraindicated. Lidocaine is ineffective for TdP.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient presents with hemodynamically unstable Torsades de Pointes (TdP). The universal standard of care for any hemodynamically unstable arrhythmia, including TdP, is immediate unsynchronized cardioversion (defibrillation). The question restricts the answer to a medication, which creates a 'No answer defensible' situation relative to the true standard of care. However, within the context of pharmacologic options, Magnesium Sulfate (Option B) is the first-line intervention for TdP according to ACLS and AHA guidelines, regardless of stability, often administered while preparing for cardioversion. The keyed answer, Isoproterenol (Option C), is a second-line therapy used for overdrive suppression (chemical pacing) to prevent recurrence, typically after magnesium fails or while awaiting transvenous pacing. The author’s rationale claiming isoproterenol is preferred in unstable patients is medically false; unstable patients require electricity, and magnesium is the standard initial drug. Furthermore, isoproterenol is an infusion, making it inappropriate for immediate rescue of an unstable patient compared to a bolus or shock. The item is miskeyed (Option B is the best available drug) and medically inaccurate.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient presents with hemodynamically unstable Torsades de Pointes (TdP). The universal standard of care for any hemodynamically unstable arrhythmia, including TdP, is immediate unsynchronized cardioversion (defibrillation). The question restricts the answer to a medication, which creates a 'No answer defensible' situation relative to the true standard of care. However, within the context of pharmacologic options, Magnesium Sulfate (Option B) is the first-line intervention for TdP according to ACLS and AHA guidelines, regardless of stability, often administered while preparing for cardioversion. The keyed answer, Isoproterenol (Option C), is a second-line therapy used for overdrive suppression (chemical pacing) to prevent recurrence, typically after magnesium fails or while awaiting transvenous pacing. The author’s rationale claiming isoproterenol is preferred in unstable patients is medically false; unstable patients require electricity, and magnesium is the standard initial drug. Furthermore, isoproterenol is an infusion, making it inappropriate for immediate rescue of an unstable patient compared to a bolus or shock. The item is miskeyed (Option B is the best available drug) and medically inaccurate.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-018", "question": "A mother is undergoing forensic psychiatric evaluation for allegedly causing medical illness in her child (factitious disorder imposed on another). She denies any intentional behavior. Which assessment tool is specifically designed to detect malingering and factitious behavior in forensic settings?", "options": ["Minnesota Multiphasic Personality Inventory-2 (MMPI-2)", "Structured Interview of Reported Symptoms (SIRS)", "Miller Forensic Assessment of Symptoms Test (M-FAST)", "Personality Assessment Inventory (PAI)", "Hare Psychopathy Checklist-Revised (PCL-R)"], "answer": "C", "answer_index": 2, "explanation": "The M-FAST is a brief screening tool specifically designed to assess malingering and symptom exaggeration in forensic evaluations. It has validated cut-off scores for detecting factitious presentations. While the MMPI-2 and PAI have validity scales, they are not as specific for factitious disorders. The SIRS assesses malingered psychosis, not factitious behavior. The PCL-R assesses psychopathy traits, not symptom validity.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question asks for a tool \\\"specifically designed\\\" to detect malingering and factitious behavior. Both the SIRS (Option B) and M-FAST (Option C) are specifically designed for this purpose. The SIRS is widely recognized as the \\\"gold standard\\\" comprehensive structured interview for detecting feigned psychopathology, while the M-FAST is a brief screening tool. Without the qualifier \\\"screening\\\" or \\\"brief\\\" in the stem, the SIRS is the statistically and clinically superior answer. The rationale incorrectly disqualifies the SIRS by claiming it only assesses \\\"malingered psychosis\\\" and not \\\"factitious behavior\\\"; in reality, both tools detect the feigning of symptoms, and the distinction between malingering and factitious disorder lies in the motivation (external vs. internal), which the tools themselves do not determine. Furthermore, the clinical vignette describes a mother denying intentional behavior (defensiveness/minimization), whereas M-FAST and SIRS are designed to detect the exaggeration or fabrication of symptoms (faking bad). A defensive examinee is typically assessed using the validity scales of the MMPI-2 (Option A) or PAI to detect under-reporting. Consequently, the item is flawed because Option B is a superior answer to the key (Option C), and the clinical scenario does not align well with the use of either tool.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question asks for a tool \"specifically designed\" to detect malingering and factitious behavior. Both the SIRS (Option B) and M-FAST (Option C) are specifically designed for this purpose. The SIRS is widely recognized as the \"gold standard\" comprehensive structured interview for detecting feigned psychopathology, while the M-FAST is a brief screening tool. Without the qualifier \"screening\" or \"brief\" in the stem, the SIRS is the statistically and clinically superior answer. The rationale incorrectly disqualifies the SIRS by claiming it only assesses \"malingered psychosis\" and not \"factitious behavior\"; in reality, both tools detect the feigning of symptoms, and the distinction between malingering and factitious disorder lies in the motivation (external vs. internal), which the tools themselves do not determine. Furthermore, the clinical vignette describes a mother denying intentional behavior (defensiveness/minimization), whereas M-FAST and SIRS are designed to detect the exaggeration or fabrication of symptoms (faking bad). A defensive examinee is typically assessed using the validity scales of the MMPI-2 (Option A) or PAI to detect under-reporting. Consequently, the item is flawed because Option B is a superior answer to the key (Option C), and the clinical scenario does not align well with the use of either tool.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-019", "question": "A 35-year-old man with treatment-resistant schizophrenia on clozapine 500 mg daily develops severe nocturnal sialorrhea with recurrent aspiration pneumonia. Which medication is most effective for this side effect?", "options": ["Benztropine 2 mg at bedtime", "Atropine ophthalmic solution 1% administered sublingually at bedtime", "Amantadine 100 mg twice daily", "Glycopyrrolate 1 mg twice daily", "Ipratropium bromide nasal spray"], "answer": "B", "answer_index": 1, "explanation": "Clozapine-induced sialorrhea is mediated by muscarinic M3 receptor agonism. Sublingual atropine ophthalmic solution provides potent anticholinergic effects locally, reducing salivation without significant systemic side effects. Glycopyrrolate and benztropine have poor CNS penetration and are less effective for nocturnal sialorrhea. Amantadine is ineffective for this side effect. Ipratropium nasal spray has minimal effect on salivation.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible). \\nVerdict: No unique best answer between B and D based on the provided stem and standard medical knowledge.\\n\\nThe vignette describes clozapine-induced sialorrhea requiring treatment. While the keyed answer, Atropine ophthalmic solution (B), is a valid off-label treatment, Glycopyrrolate (D) is also a widely accepted, effective, first-line pharmacological intervention for this condition. The provided rationale for excluding Glycopyrrolate—that it has \\\"poor CNS penetration and [is] less effective\\\"—is medically unsound. Sialorrhea is a peripheral autonomic side effect; therefore, CNS penetration is not required for efficacy. In fact, Glycopyrrolate's inability to cross the blood-brain barrier is clinically advantageous, as it reduces the risk of central anticholinergic toxicity (e.g., confusion, delirium) in patients already taking clozapine. Additionally, the explanation attributes the sialorrhea to M3 agonism, whereas clozapine is a potent M3 antagonist (the mechanism is likely M4 agonism or alpha-2 antagonism). Because both B and D are standard-of-care options and the discrimination logic is flawed, the item fails to have a single best answer.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible). \nVerdict: No unique best answer between B and D based on the provided stem and standard medical knowledge.\n\nThe vignette describes clozapine-induced sialorrhea requiring treatment. While the keyed answer, Atropine ophthalmic solution (B), is a valid off-label treatment, Glycopyrrolate (D) is also a widely accepted, effective, first-line pharmacological intervention for this condition. The provided rationale for excluding Glycopyrrolate—that it has \"poor CNS penetration and [is] less effective\"—is medically unsound. Sialorrhea is a peripheral autonomic side effect; therefore, CNS penetration is not required for efficacy. In fact, Glycopyrrolate's inability to cross the blood-brain barrier is clinically advantageous, as it reduces the risk of central anticholinergic toxicity (e.g., confusion, delirium) in patients already taking clozapine. Additionally, the explanation attributes the sialorrhea to M3 agonism, whereas clozapine is a potent M3 antagonist (the mechanism is likely M4 agonism or alpha-2 antagonism). Because both B and D are standard-of-care options and the discrimination logic is flawed, the item fails to have a single best answer.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed129", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed129-020", "question": "A 40-year-old Puerto Rican woman presents to the emergency department with acute episode of screaming, crying, trembling, and feeling detached from her body after receiving news of her mother's death. Family reports this is an 'ataque de nervios.' Which of the following is the most appropriate DSM-5 diagnosis?", "options": ["Panic disorder, with cultural idiom", "Dissociative identity disorder", "Acute stress disorder", "Other specified trauma- and stressor-related disorder (ataque de nervios)", "No psychiatric diagnosis; this is a culturally normative expression of grief"], "answer": "D", "answer_index": 3, "explanation": "'Ataque de nervios' is recognized in DSM-5 as a cultural syndrome that can be classified under 'Other specified trauma- and stressor-related disorder' when symptoms cause clinically significant distress. It is not considered a normative expression of grief when it results in functional impairment. While it shares features with panic and dissociative disorders, the specific cultural framework warrants its own diagnostic category. Acute stress disorder requires more persistent symptoms beyond the acute episode.", "generator_model": "kimi-k2-thinking", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of 'ataque de nervios,' a cultural syndrome characterized by intense emotional upset, screaming, trembling, and dissociation, triggered by a major stressor. The DSM-5 Glossary of Cultural Concepts of Distress links this syndrome to several potential categories, including 'Other specified anxiety disorder' and 'Other specified trauma- and stressor-related disorder,' depending on the predominant symptoms and trigger. Given the clear precipitating stressor (death of mother) and the failure to meet criteria for Acute Stress Disorder (Option C requires duration >3 days) or Panic Disorder (Option A requires recurrent/unexpected attacks), Option D is the most appropriate diagnostic category among the choices. Option E is a strong distractor because 'ataque' is often a normative idiom of distress; however, in a board-exam context, presentation to the Emergency Department serves as the proxy for 'clinically significant distress or impairment,' which differentiates a diagnosable 'Other specified' disorder from a non-pathological reaction. Therefore, D is the intended and defensible best answer. The item is logically valid and medically accurate.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of 'ataque de nervios,' a cultural syndrome characterized by intense emotional upset, screaming, trembling, and dissociation, triggered by a major stressor. The DSM-5 Glossary of Cultural Concepts of Distress links this syndrome to several potential categories, including 'Other specified anxiety disorder' and 'Other specified trauma- and stressor-related disorder,' depending on the predominant symptoms and trigger. Given the clear precipitating stressor (death of mother) and the failure to meet criteria for Acute Stress Disorder (Option C requires duration >3 days) or Panic Disorder (Option A requires recurrent/unexpected attacks), Option D is the most appropriate diagnostic category among the choices. Option E is a strong distractor because 'ataque' is often a normative idiom of distress; however, in a board-exam context, presentation to the Emergency Department serves as the proxy for 'clinically significant distress or impairment,' which differentiates a diagnosable 'Other specified' disorder from a non-pathological reaction. Therefore, D is the intended and defensible best answer. The item is logically valid and medically accurate.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]